Education & Academic Qualifications
- Medical School, Aristotelion University, Thessaloniki, Greece, 1984
- Research Fellow on Breast Cancer, JCRT, Harvard Medical School, 1992-1994
Immunohistochemical study of hyperplastic and neoplastic endometrium with antibodies against CEA and ferritin, Athens Medical School, 1991
Fellowship in Societies, Membership in Journal Editorial Committees
Hellenic Mastology Society
Clinical & Research Interest
Clinical Interest: Breast Cancer Surgery, and reconstruction, new treatment approaches on breast Cancer
Research Interest: Familial Breast Cancer, Risk management
Honors & Awards
New therapeutic approaches in breast cancer, Washington DC, 1994
Depressive symptoms during adverse economic and political circumstances: A comparative study on Greek female breast cancer patients receiving chemotherapy treatment. Eur J Care, 2017.
Development of a novel PTT assay for mutation detection in PALB2 large exons and PALB2 screening in medullary breast cancer. Familial Cancer, 2016, 15:183-191.
Durable Clinical Benefit of Pertuzumab in a Young Patient with BRCA2 Mutation and HER2- Overexpressing Breast Cancer Involving the Brain. Case Rep Oncol Med, 2016.
High prevalence of BRCA1 founder mutations in Greek breast/ ovarian families. Clin Genet. 2014.